Jazz Pharmaceuticals
Price & Volume
Stats
See moreOpen | $138.86 |
Previous Close | $137.78 |
Day Range | $138.56-$139.18 |
52W Range | $95.49-$148.06 |
Market Cap | $8.3B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $4B |
Revenue Growth (YoY) | 2.1% |
Gross Profit (12 Mos) | $3.7B |
Diluted EPS | -$6.98 |
News
See moreYahoo Finance • 23 days ago
Jazz Pharmaceuticals plc (JAZZ) Wins FDA Nod for Modeyso in Rare Pediatric Brain Tumors
Yahoo Finance • 28 days ago
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem
Yahoo Finance • 29 days ago
Chronic Myelomonocytic Leukemia Market Analysis and Forecast Report 2025-2035, with Profiles of AbbVie, GlaxoSmithKline, Incyte, Jazz Pharmaceuticals, Novartis, Stemline Therapeutics, and More
Yahoo Finance • 2 months ago
Jazz Pharmaceuticals Enters Into Global License Agreement To Develop SAN2355
About
CEO | Ms. Renee D. Gala |
CFO | Mr. Philip L. Johnson |
Address | Waterloo Exchange, Dublin, Ireland, D04 E5W7 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,800 |
